CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 517238-517458 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T49433","span":{"begin":0,"end":220},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Finally, we tested HQ in monophasic EAE and found that 100 mg/kg given as a pretreatment completely prevented the development of disease; this was correlated with lack of signs of microglia activation in treated animals."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1073","span":{"begin":0,"end":220},"obj":"Epistemic_statement"}],"text":"Finally, we tested HQ in monophasic EAE and found that 100 mg/kg given as a pretreatment completely prevented the development of disease; this was correlated with lack of signs of microglia activation in treated animals."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T352","span":{"begin":0,"end":220},"obj":"Sentence"}],"text":"Finally, we tested HQ in monophasic EAE and found that 100 mg/kg given as a pretreatment completely prevented the development of disease; this was correlated with lack of signs of microglia activation in treated animals."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1035","span":{"begin":36,"end":39},"obj":"Phenotype"}],"attributes":[{"id":"A1035","pred":"hp_id","subj":"T1035","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"Finally, we tested HQ in monophasic EAE and found that 100 mg/kg given as a pretreatment completely prevented the development of disease; this was correlated with lack of signs of microglia activation in treated animals."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3549","span":{"begin":36,"end":39},"obj":"Disease"},{"id":"T25020","span":{"begin":36,"end":39},"obj":"Disease"}],"attributes":[{"id":"A3549","pred":"mondo_id","subj":"T3549","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A3550","pred":"mondo_id","subj":"T3549","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A3551","pred":"mondo_id","subj":"T3549","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A55172","pred":"mondo_id","subj":"T25020","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A9378","pred":"mondo_id","subj":"T25020","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A84250","pred":"mondo_id","subj":"T25020","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"}],"text":"Finally, we tested HQ in monophasic EAE and found that 100 mg/kg given as a pretreatment completely prevented the development of disease; this was correlated with lack of signs of microglia activation in treated animals."}